Glenn Saldanha, managing director and CEO of Glenmark Pharmaceuticals, in an interview with CNBC-TV18's Udayan Mukherjee and Mitali Mukherjee, said that its business in India is growing at 23-24%, while its business in US is expected to grow 25% in FY12.
first published: May 11, 2011 10:46 am
A collection of the most-viewed Moneycontrol videos.
The Tenant Diwali Special: From Mumbai Slums to Alibaug Villas: 2025 Recap
Nifty Snaps 6-Day Winning Streak As Markets Get In Consolidation Mode| Closing Bell Live
Kenneth Andrade picks three unusual, ignored sectors to bet on in Samvat 2082
Nifty Likely To Consolidate Until It Clears 26,000 Mark Decisively | Opening Bell Live
